We observed that the heregulin mRNA level is significantly greater in anti-EGFR antibody cetuximab-resistant HNSCC FaDuCR cells than in cetuximab-sensitive FaDu cells [32]. Here, EGFR is linked to head and neck squamous cell carcinoma.